Bioventus Inc. (BVS)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 200M 400M 600M Q4 '20: 321.2M Q2 '21: 324.3M Q3 '21: 376.1M Q4 '21: 399.1M Q4 '21: 430.9M Q2 '22: 466.4M Q3 '22: 496.9M Q4 '22: 516.7M Q4 '22: 512.1M Q2 '23: 513.9M Q3 '23: 510.6M Q3 '23: 502.8M Q4 '23: 512.3M Q1 '24: 522.7M Q2 '24: 536.9M Q3 '24: 555.1M Q4 '24: 573.3M Q1 '25: 567.7M Q2 '25: 564.1M Q3 '25: 563.8M Q4 '25: 568.1M Q1 '26: 576.3M Q2 '26: 581.8M Q2 '21 Q4 '21 Q4 '22 Q3 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

0 150M 300M 450M Q4 '20: 233.5M Q2 '21: 235.8M Q3 '21: 271.8M Q4 '21: 288.4M Q4 '21: 302.7M Q2 '22: 318.9M Q3 '22: 339.2M Q4 '22: 344.7M Q4 '22: 331.1M Q2 '23: 329.3M Q3 '23: 321.8M Q3 '23: 316.1M Q4 '23: 328.2M Q1 '24: 342.7M Q2 '24: 357.2M Q3 '24: 371.9M Q4 '24: 388.2M Q1 '25: 382.9M Q2 '25: 381.4M Q3 '25: 382M Q4 '25: 388.2M Q1 '26: 395.9M Q2 '26: 399.4M Q2 '21 Q4 '21 Q4 '22 Q3 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income TTM

-270M -180M -90M 0 90M 180M 270M Q4 '20: 21.2M Q2 '21: 30.2M Q3 '21: 29.1M Q4 '21: 21.1M Q4 '21: 12.1M Q2 '22: -31.4M Q3 '22: -29M Q4 '22: -154.7M Q4 '22: -167.2M Q2 '23: -237.8M Q3 '23: -227.8M Q3 '23: -98.5M Q4 '23: -81.7M Q1 '24: 15.3M Q2 '24: -23M Q3 '24: -21.7M Q4 '24: -15.2M Q1 '25: -15.3M Q2 '25: 34.6M Q3 '25: 42.2M Q4 '25: 54M Q1 '26: 57.5M Q2 '26: 58.3M Q2 '21 Q4 '21 Q4 '22 Q3 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

-300M -200M -100M 0 100M 200M 300M Q4 '20: 16.4M Q2 '21: 30.4M Q3 '21: 32M Q4 '21: 22.5M Q4 '21: 19.4M Q2 '22: -16.8M Q3 '22: -20M Q4 '22: -127.1M Q4 '22: -158.7M Q2 '23: -286.6M Q3 '23: -283M Q3 '23: -182.1M Q4 '23: -156.2M Q1 '24: -22M Q2 '24: -44M Q3 '24: -41.8M Q4 '24: -36.1M Q1 '25: -33.9M Q2 '25: -731K Q3 '25: 7.6M Q4 '25: 22.7M Q1 '26: 28.5M Q2 '26: 54.5M Q2 '21 Q4 '21 Q4 '22 Q3 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 70M 140M 210M Q4 '20: 87.6M Q2 '21: 88.5M Q3 '21: 104.3M Q4 '21: 110.7M Q4 '21: 128.2M Q2 '22: 147.6M Q3 '22: 157.7M Q4 '22: 172M Q4 '22: 181M Q2 '23: 184.6M Q3 '23: 188.9M Q3 '23: 186.7M Q4 '23: 184.2M Q1 '24: 180.1M Q2 '24: 179.7M Q3 '24: 183.2M Q4 '24: 185.1M Q1 '25: 184.8M Q2 '25: 182.8M Q3 '25: 181.8M Q4 '25: 179.9M Q1 '26: 180.4M Q2 '26: 182.4M Q2 '21 Q4 '21 Q4 '22 Q3 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

-35M 0 35M 70M 105M Q4 '20: 71.8M Q2 '21: 36.1M Q3 '21: 45.6M Q4 '21: 35.3M Q4 '21: 23M Q2 '22: 20M Q3 '22: 5.6M Q4 '22: -5.7M Q4 '22: -13.5M Q2 '23: 10M Q3 '23: 17.8M Q3 '23: 10.2M Q4 '23: 15.3M Q1 '24: 6.8M Q2 '24: 11.2M Q3 '24: 29.8M Q4 '24: 38.8M Q1 '25: 25.5M Q2 '25: 36.2M Q3 '25: 56M Q4 '25: 74.7M Q1 '26: 102.9M Q2 '26: 96.9M Q2 '21 Q4 '21 Q4 '22 Q3 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

-35M 0 35M 70M 105M Q4 '20: 55.2M Q2 '21: 18.4M Q3 '21: 27.4M Q4 '21: 16.5M Q4 '21: 9.5M Q2 '22: 4.9M Q3 '22: -10.2M Q4 '22: -21.3M Q4 '23: 8M Q1 '24: 2.8M Q2 '24: 8.4M Q3 '24: 29M Q4 '24: 37.8M Q1 '25: 23.9M Q2 '25: 34.1M Q3 '25: 53.5M Q4 '25: 72.1M Q1 '26: 100.6M Q2 '26: 94.3M Q4 '20 Q4 '21 Q3 '22 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 25M 50M 75M Q2 '21: 41.8M Q3 '21: 41.8M Q4 '21: 41.8M Q2 '22: 60.5M Q3 '22: 61.5M Q4 '22: 61.7M Q2 '23: 62.1M Q3 '23: 62.6M Q3 '23: 62.8M Q1 '24: 63.4M Q2 '24: 64.1M Q3 '24: 65.3M Q1 '25: 66M Q2 '25: 68.5M Q3 '25: 68.8M Q1 '26: 70M Q2 '26: 70.8M Q3 '21 Q3 '22 Q3 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-6.00 -4.00 -2.00 0.00 2.00 4.00 6.00 Q2 '22: -0.32 Q3 '22: -0.33 Q4 '22: -2.06 Q4 '22: -2.58 Q2 '23: -4.63 Q3 '23: -4.58 Q3 '23: -2.94 Q4 '23: -2.51 Q1 '24: -0.35 Q2 '24: -0.69 Q3 '24: -0.65 Q4 '24: -0.56 Q1 '25: -0.52 Q2 '25: -0.01 Q3 '25: 0.12 Q4 '25: 0.33 Q1 '26: 0.41 Q2 '26: 0.77 Q4 '22 Q3 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.